List of Tables
    Table 1. Diabetic Therapeutic Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Diabetic Therapeutic Drugs Market Trends
    Table 3. Diabetic Therapeutic Drugs Market Drivers
    Table 4. Diabetic Therapeutic Drugs Market Challenges
    Table 5. Diabetic Therapeutic Drugs Market Restraints
    Table 6. Global Diabetic Therapeutic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Diabetic Therapeutic Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Diabetic Therapeutic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Diabetic Therapeutic Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Diabetic Therapeutic Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Diabetic Therapeutic Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Diabetic Therapeutic Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Diabetic Therapeutic Drugs Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Diabetic Therapeutic Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Diabetic Therapeutic Drugs Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Diabetic Therapeutic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Diabetic Therapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Therapeutic Drugs as of 2021)
    Table 18. Top Players of Diabetic Therapeutic Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Diabetic Therapeutic Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Diabetic Therapeutic Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Diabetic Therapeutic Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Diabetic Therapeutic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Diabetic Therapeutic Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Diabetic Therapeutic Drugs Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Diabetic Therapeutic Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Diabetic Therapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Diabetic Therapeutic Drugs Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Diabetic Therapeutic Drugs Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Diabetic Therapeutic Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Diabetic Therapeutic Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Diabetic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Diabetic Therapeutic Drugs Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Diabetic Therapeutic Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Diabetic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Diabetic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Diabetic Therapeutic Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Diabetic Therapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Diabetic Therapeutic Drugs Product
    Table 46. AstraZeneca Recent Development
    Table 47. Eli Lilly Corporation Information
    Table 48. Eli Lilly Description and Business Overview
    Table 49. Eli Lilly Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. Eli Lilly Product
    Table 51. Eli Lilly Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. Novo Nordisk Corporation Information
    Table 58. Novo Nordisk Description and Business Overview
    Table 59. Novo Nordisk Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. Novo Nordisk Product
    Table 61. Novo Nordisk Recent Development
    Table 62. Sanofi Corporation Information
    Table 63. Sanofi Description and Business Overview
    Table 64. Sanofi Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. Sanofi Product
    Table 66. Sanofi Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Novartis Corporation Information
    Table 73. Novartis Description and Business Overview
    Table 74. Novartis Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. Novartis Product
    Table 76. Novartis Recent Development
    Table 77. Perle Biosciences Corporation Information
    Table 78. Perle Biosciences Description and Business Overview
    Table 79. Perle Biosciences Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. Perle Biosciences Product
    Table 81. Perle Biosciences Recent Development
    Table 82. Sun Pharma Corporation Information
    Table 83. Sun Pharma Description and Business Overview
    Table 84. Sun Pharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 85. Sun Pharma Product
    Table 86. Sun Pharma Recent Development
    Table 87. Takeda Pharmaceuticals Corporation Information
    Table 88. Takeda Pharmaceuticals Description and Business Overview
    Table 89. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 90. Takeda Pharmaceuticals Product
    Table 91. Takeda Pharmaceuticals Recent Development
    Table 92. F. Hoffmann-La Roche Corporation Information
    Table 93. F. Hoffmann-La Roche Description and Business Overview
    Table 94. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 95. F. Hoffmann-La Roche Product
    Table 96. F. Hoffmann-La Roche Recent Development
    Table 97. Belrose Pharma Corporation Information
    Table 98. Belrose Pharma Description and Business Overview
    Table 99. Belrose Pharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 100. Belrose Pharma Product
    Table 101. Belrose Pharma Recent Development
    Table 102. Mitsubishi Tanabe Pharma Corporation Information
    Table 103. Mitsubishi Tanabe Pharma Description and Business Overview
    Table 104. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 105. Mitsubishi Tanabe Pharma Product
    Table 106. Mitsubishi Tanabe Pharma Recent Development
    Table 107. Dong-A ST Corporation Information
    Table 108. Dong-A ST Description and Business Overview
    Table 109. Dong-A ST Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 110. Dong-A ST Product
    Table 111. Dong-A ST Recent Development
    Table 112. Eisai Corporation Information
    Table 113. Eisai Description and Business Overview
    Table 114. Eisai Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 115. Eisai Product
    Table 116. Eisai Recent Development
    Table 117. Arbutus Biopharma Corporation Information
    Table 118. Arbutus Biopharma Description and Business Overview
    Table 119. Arbutus Biopharma Diabetic Therapeutic Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 120. Arbutus Biopharma Product
    Table 121. Arbutus Biopharma Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Diabetic Therapeutic Drugs Customers List
    Table 125. Diabetic Therapeutic Drugs Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Diabetic Therapeutic Drugs Product Picture
    Figure 2. Global Diabetic Therapeutic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Diabetic Therapeutic Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Diabetic Therapeutic Drugs Sales 2017-2028 (MT)
    Figure 5. United States Diabetic Therapeutic Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Diabetic Therapeutic Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Diabetic Therapeutic Drugs Sales 2017-2028 (MT)
    Figure 8. United States Diabetic Therapeutic Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Diabetic Therapeutic Drugs Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Diabetic Therapeutic Drugs Report Years Considered
    Figure 11. Product Picture of Insulin Therapies
    Figure 12. Product Picture of Non-Insulin Therapies
    Figure 13. Global Diabetic Therapeutic Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Diabetic Therapeutic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Diabetic Therapeutic Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Diabetic Therapeutic Drugs Sales by Type (2017-2028) & (MT)
    Figure 17. Global Diabetic Therapeutic Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Diabetic Therapeutic Drugs Price by Type (2017-2028) & (USD/Kg)
    Figure 19. United States Diabetic Therapeutic Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Diabetic Therapeutic Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Diabetic Therapeutic Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Diabetic Therapeutic Drugs Sales by Type (2017-2028) & (MT)
    Figure 23. United States Diabetic Therapeutic Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Diabetic Therapeutic Drugs Price by Type (2017-2028) & (USD/Kg)
    Figure 25. Product Picture of Type 1 Diabetes
    Figure 26. Product Picture of Type 2 Diabetes
    Figure 27. Product Picture of Gestational Diabetes
    Figure 28. Global Diabetic Therapeutic Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Diabetic Therapeutic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Diabetic Therapeutic Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Diabetic Therapeutic Drugs Sales by Application (2017-2028) & (MT)
    Figure 32. Global Diabetic Therapeutic Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Diabetic Therapeutic Drugs Price by Application (2017-2028) & (USD/Kg)
    Figure 34. United States Diabetic Therapeutic Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Diabetic Therapeutic Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Diabetic Therapeutic Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Diabetic Therapeutic Drugs Sales by Application (2017-2028) & (MT)
    Figure 38. United States Diabetic Therapeutic Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Diabetic Therapeutic Drugs Price by Application (2017-2028) & (USD/Kg)
    Figure 40. North America Diabetic Therapeutic Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 41. North America Diabetic Therapeutic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Diabetic Therapeutic Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 45. Europe Diabetic Therapeutic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Diabetic Therapeutic Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 52. Asia-Pacific Diabetic Therapeutic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Diabetic Therapeutic Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 64. Latin America Diabetic Therapeutic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Diabetic Therapeutic Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 69. Middle East & Africa Diabetic Therapeutic Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Diabetic Therapeutic Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Diabetic Therapeutic Drugs Value Chain
    Figure 74. Diabetic Therapeutic Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed